Raymond James Financial Services Advisors, Inc. - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 27 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$144,566
+35.3%
146,000
+33.9%
0.00%
Q4 2022$106,823
+1.7%
109,0000.0%0.00%
Q3 2022$105,000
+72.1%
109,000
+70.3%
0.00%
Q2 2022$61,000
+32.6%
64,000
+28.0%
0.00%
Q1 2022$46,000
-2.1%
50,0000.0%0.00%
Q4 2021$47,000
+4.4%
50,0000.0%0.00%
Q3 2021$45,000
-50.0%
50,000
-50.0%
0.00%
Q2 2021$90,000
+11.1%
100,0000.0%0.00%
Q1 2021$81,000
+44.6%
100,000
+38.9%
0.00%
Q4 2020$56,000
-59.1%
72,000
-57.6%
0.00%
Q3 2020$137,000
-9.3%
170,000
-15.0%
0.00%
Q2 2020$151,000
-32.6%
200,000
-28.6%
0.00%
-100.0%
Q1 2020$224,000
-20.6%
280,0000.0%0.00%0.0%
Q4 2019$282,000
-11.3%
280,000
-24.3%
0.00%0.0%
Q3 2019$318,000
-3.6%
370,0000.0%0.00%0.0%
Q2 2019$330,000
-9.8%
370,0000.0%0.00%
-50.0%
Q1 2019$366,000
+18.4%
370,000
+10.4%
0.00%0.0%
Q4 2018$309,000
-8.8%
335,0000.0%0.00%0.0%
Q3 2018$339,000335,0000.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Silver Point Capital L.P. 57,420,000$44,527,0005.17%
Birch Grove Capital LP 10,003,000$7,934,0004.14%
PenderFund Capital Management Ltd. 9,605,000$9,491,0002.41%
Context Capital Management, LLC 9,887,000$7,671,0001.05%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 57,791,000$45,738,0000.90%
DeepCurrents Investment Group LLC 35,892,000$27,953,0000.74%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 22,977,000$18,267,0000.70%
WHITEBOX ADVISORS LLC 23,150,000$17,847,0000.56%
ADVENT CAPITAL MANAGEMENT /DE/ 27,397,000$21,720,0000.46%
OAKTREE CAPITAL MANAGEMENT LP 19,435,000$15,079,0000.26%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders